Literature DB >> 16434649

Virtual reality cues for improvement of gait in patients with multiple sclerosis.

Yoram Baram1, Ariel Miller.   

Abstract

OBJECTIVE: To study the effects of visual cues, provided through a portable visual-feedback virtual reality (VR) apparatus, on the walking abilities of patients with multiple sclerosis (MS).
METHODS: On-line (display-on) and residual short-term therapeutic effects on walking speed and stride length were measured in 16 randomly selected patients with gait disturbances predominantly due to cerebellar ataxia.
RESULTS: Patients whose baseline walking speed (BWS) was below the median showed an average on-line improvement of 13.46% in their walking speed, while patients whose BWS was above the median improved their speed by 1.47%. The average short-term residual therapeutic improvement in walking speed was 24.49% in patients with BWS below the median, and 9.09% in patients with BWS above the median. Similar results were obtained for improvements in stride length. These results of improved functions in patients are particularly noteworthy when compared with the lack of change in healthy control subjects.
CONCLUSIONS: Patients with multiple sclerosis showed improvement in walking abilities using virtual reality visual-feedback cues.

Entities:  

Mesh:

Year:  2006        PMID: 16434649     DOI: 10.1212/01.wnl.0000194255.82542.6b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Virtual reality in neuroscience research and therapy.

Authors:  Corey J Bohil; Bradly Alicea; Frank A Biocca
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 2.  The Effects of Sensory Manipulations on Motor Behavior: From Basic Science to Clinical Rehabilitation.

Authors:  Taisei Sugiyama; Sook-Lei Liew
Journal:  J Mot Behav       Date:  2016-12-09       Impact factor: 1.328

3.  Needs Assessment-mHealth Applications for People Aging with Multiple Sclerosis.

Authors:  Ljilja Ruzic; Jon A Sanford
Journal:  J Healthc Inform Res       Date:  2018-05-10

Review 4.  The effectiveness of allied health care in patients with ataxia: a systematic review.

Authors:  Ella M R Fonteyn; Samyra H J Keus; Carla C P Verstappen; Ludger Schöls; Imelda J M de Groot; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

5.  Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis.

Authors:  Marcin Uszynski; Helen Purtill; Susan Coote
Journal:  Int J MS Care       Date:  2016 Mar-Apr

6.  Preservation of motor skill learning in patients with multiple sclerosis.

Authors:  Valentina Tomassini; Heidi Johansen-Berg; Laura Leonardi; Luis Paixão; Saad Jbabdi; Jackie Palace; Carlo Pozzilli; Paul M Matthews
Journal:  Mult Scler       Date:  2010-09-10       Impact factor: 6.312

7.  The Effects of Exergame on Postural Control in Individuals with Ataxia: a Rater-Blinded, Randomized Controlled, Cross-over Study.

Authors:  Ender Ayvat; Özge Onursal Kılınç; Fatma Ayvat; Cevher Savcun Demirci; Sibel Aksu Yıldırım; Oğuzhan Kurşun; Muhammed Kılınç
Journal:  Cerebellum       Date:  2021-05-11       Impact factor: 3.648

8.  A kinematic analysis of a haptic handheld stylus in a virtual environment: a study in healthy subjects.

Authors:  Jurgen Broeren; Katharina S Sunnerhagen; Martin Rydmark
Journal:  J Neuroeng Rehabil       Date:  2007-05-09       Impact factor: 4.262

Review 9.  Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disorders.

Authors:  Frédéric D Broccard; Tim Mullen; Yu Mike Chi; David Peterson; John R Iversen; Mike Arnold; Kenneth Kreutz-Delgado; Tzyy-Ping Jung; Scott Makeig; Howard Poizner; Terrence Sejnowski; Gert Cauwenberghs
Journal:  Ann Biomed Eng       Date:  2014-05-15       Impact factor: 3.934

Review 10.  Virtual sensory feedback for gait improvement in neurological patients.

Authors:  Yoram Baram
Journal:  Front Neurol       Date:  2013-10-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.